Back to search

Article

Variation in First-line Type 2 Diabetes Treatment due to eGFR and Provider Preferences: A Novel Statistical Analysis

2024-09-22

Abstract excerpt

<h4>Introduction</h4> The decision between metformin and a DPP-4 inhibitor or sulfonylurea for first-line type 2 diabetes treatment relies on many factors, including estimated glomerular filtration rate (eGFR), history of heart failure, age, sex, and even provider preferences. This study evaluates variation in this treatment decision across two factors: eGFR and provider preferences. <h4>Research Design and Method...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
0a866bfc-69a2-5702-ac05-cf35a55c5fbf
DOI
10.1101/2024.09.19.24313155
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Variation in First-line Type 2 Diabetes Treatment due to eGFR and Provider Preferences: A Novel Statistical AnalysisDOI 10.1101/2024.09.19.24313155
Derivation and validation of a type 2 diabetes treatment selection algorithm for SGLT2-inhibitor and DPP4-inhibitor therapies based on glucose-lowering efficacy: cohort study using trial and routine clinical dataSemantic proximity
Use of real-world evidence data to evaluate the comparative effectiveness of second-line type 2 diabetes medications on chronic kidney diseaseSemantic proximity
Heterogeneity of Treatment Effects of Glucose-lowering Drug Classes for Type 2 Diabetes: LEGEND-T2DM Network Real-World EvidenceSemantic proximity
Estimating Heritability of Glycaemic Response to Metformin using Nationwide Electronic Health Records and Population-Sized PedigreeSemantic proximity
The Influence of Age, Sex, and Socioeconomic Status on Glycemic Control Among People with Type 1 and Type 2 Diabetes in Canada: A Patient-Led Longitudinal Retrospective Cohort StudySemantic proximity
Predicting Unplanned Medical Visits Among Patients with Diabetes: Translation From Machine Learning to Clinical ImplementationSemantic proximity
Hospital and patient influencing factors of treatment schemes given to type 2 diabetes mellitus inpatients in Inner Mongolia, ChinaSemantic proximity
Where risk becomes visible: a layered fixed-policy framework for diabetic kidney disease screening in type 2 diabetesSemantic proximity
Heterogeneity of Treatment Effects Across Nine Glucose-Lowering Drug Classes in Type 2 Diabetes: Extension of the LEGEND-T2DM Network StudySemantic proximity
Renal outcomes of combination therapy with sodium-glucose cotransporter 2 inhibitors plus renin-angiotensin system blockers in patients with type 2 diabetes mellitus: A population-based cohort studySemantic proximity
Estimating Heritability of Glycaemic Response to Metformin using Nationwide Electronic Health Records and Population-Sized PedigreeSemantic proximity
Clinical interpretation of machine learning models for prediction of diabetic complications using electronic health recordsSemantic proximity
Select a neighboring publication to make it the new centre.